1YW5

Peptidyl-prolyl isomerase ESS1 from Candida albicans

1YW5 の概要

• エントリーDOI: 10.2210/pdb1yw5/pdb
• 分子名称: peptidyl prolyl cis/trans isomerase (2 entities in total)
• 機能のキーワード: ww-domain, ppiase domain, ordered linker, isomerase
• 由来する生物種: Candida albicans
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 19883.12

構造登録者

Li, Z.,Li, H.,Devasahayam, G.,Gemmill, T.,Chaturvedi, V.,Hanes, S.D.,Van Roey, P. (登録日: 2005-02-17, 公開日: 2005-04-26, 最終更新日: 2024-02-14)

主引用文献

Li, Z.,Li, H.,Devasahayam, G.,Gemmill, T.,Chaturvedi, V.,Hanes, S.D.,Van Roey, P.
The Structure of the Candida albicans Ess1 Prolyl Isomerase Reveals a Well-Ordered Linker that Restricts Domain Mobility
Biochemistry, 44:6180-6189, 2005

PubMed Abstract: Ess1 is a peptidyl-prolyl cis/trans isomerase (PPIase) that binds to the carboxy-terminal domain (CTD) of RNA polymerase II. Ess1 is thought to function by inducing conformational changes in the CTD that control the assembly of cofactor complexes on the transcription unit. Ess1 (also called Pin1) is highly conserved throughout the eukaryotic kingdom and is required for growth in some species, including the human fungal pathogen Candida albicans. Here we report the crystal structure of the C. albicansEss1 protein, determined at 1.6 A resolution. The structure reveals two domains, the WW and the isomerase domain, that have conformations essentially identical to those of human Pin1. However, the linker region that joins the two domains is quite different. In human Pin1, this linker is short and flexible, and part of it is unstructured. In contrast, the fungal Ess1 linker is highly ordered and contains a long alpha-helix. This structure results in a rigid juxtaposition of the WW and isomerase domains, in an orientation that is distinct from that observed in Pin1, and that eliminates a hydrophobic pocket between the domains that was implicated as the main substrate recognition site. These differences suggest distinct modes of interaction with long substrate molecules, such as the CTD of RNA polymerase II. We also show that C. albicans ess1(-)() mutants are attenuated for in vivo survival in mice. Together, these results suggest that CaEss1 might constitute a useful antifungal drug target, and that structural differences between the fungal and human enzymes could be exploited for drug design.

PubMed: 15835905
DOI: 10.1021/bi050115l

実験手法

X-RAY DIFFRACTION (1.6 Å)